Potential for routine concurrent determination of chlamydia and cervical abnormalities by single fluid-based sampling.


Objective: The FDA recently approved adjunctive HPV testing from the vial of PreservCyt(R) Solution used for the ThinPrep(R) Pap Test. We have now evaluated the potential for routine chlamydia testing from cellular material collected for primary Pap testing using the fluid-based ThinPrep method.Methods: Cervical scrapings were collected for a conventional… (More)